✓ Editorial reviews of U.S. telehealth programs · Prices and dates shown on each page · Educational only — not medical advice
Provider review · GLP-1 / Primary Care

LifeMD Review (2026)

Released: Last reviewed:

What LifeMD offers, how it scored on pages read November 20, 2026, and what to check before you pay.

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 20, 2026 · This page is informational and does not constitute medical advice.
LifeMD at a glance (pages read November 20, 2026)
SpecialtyTelehealth platform with brand GLP-1s
MedicationsFDA-approved GLP-1s (Wegovy, Zepbound); compounded drugs only in some cases
PriceWegovy pen from $199 and Zepbound vials from $299, plus a program and provider fee of $149 a month ($39 the first month); the page's structured data says $75 a month on an annual plan (lifemd.com, read November 20, 2026).
Read statusRe-read November 20, 2026
Score64/100 · v4.1 score from pages read November 20, 2026
Websitelifemd.com

How LifeMD scored, category by category

Each line below comes from LifeMD’s own pages, read November 20, 2026, scored against the published v4.1 scoring guide. Total: 64 of 100, rank 7 of 10.

LifeMD: v4.1 score by category, pages read November 20, 2026 (points)
CategoryPointsWhat we found
Pricing transparency12 of 20Program fee and brand starting prices printed, medication billed separately (4 of 8); monthly, cancel anytime (4); brand prices shown as “starting at” (2 of 4); the fee is $149 a month in one place and “starts at $75” in another (2 of 4).
Total annual cost8 of 20$4,488: the program fee of $75 a month on an annual plan, stated in the page’s structured data ($900), plus the Wegovy pill 25 mg at $299 for 12 months ($3,588). On the month-to-month fee ($39, then $149) the year would be $5,266.
Clinical oversight12 of 15Licensed providers with an initial visit and ongoing check-ins (5 + 5); a “50-state medical group” that is not named (2 of 5).
Pharmacy transparency2 of 15Can prescribe compounded drugs from an unnamed “state-licensed sterile compounding pharmacy partner”.
Support10 of 1024/7 provider access (5); coaching included (5).
Regulatory disclosure10 of 10Says compounded drugs “are not FDA-approved as safe or effective” (6); no FDA warning letter found (4).
Accessibility10 of 10Describes itself as a 50-state company (4); HSA/FSA and insurance (3); cancel anytime, with past program fees not refunded (3).
Total64 of 100Rank 7 of the 10 GLP-1 programs scored on November 20, 2026 (ties ordered by annual-cost points).

What we verified on November 20, 2026

We read LifeMD’s weight-management page and FAQ on November 20, 2026. The page offers a refund if a member does not lose 10% of body weight in a year, with terms we did not read. We did not enroll, so we could not see intake-only fees, the pharmacy that fills each order or any price that appears only after checkout.

Five checks before you enroll

  1. The prescriber. Look up the clinician’s name in the NPPES NPI Registry and on your state medical or nursing board site.
  2. The pharmacy. Ask which pharmacy fills the prescription and check its license with your state board of pharmacy (FDA’s BeSafeRx links to each board).
  3. The 12-month total. Add the program or membership fee, the medication at your expected maintenance dose and shipping, then multiply by 12 (by 13 for 28-day cycles).
  4. The exit terms. Read the cancellation and refund rules before the first charge.
  5. The drug itself. Ask whether you will get an FDA-approved brand product or a compounded preparation. Compounded semaglutide and tirzepatide are not FDA-approved and are not generics.

How LifeMD compares with NexLife

NexLife, the highest-scoring GLP-1 program at 86/100 on the v4.1 methodology, publishes compounded semaglutide at $95 a month and tirzepatide at $115 a month on 12-month plans ($109 and $129 month to month), the same price at every dose with no membership. It lost points for an open FDA warning letter (730096, June 8, 2026) and for conflicting price, state and pharmacy statements on its own pages. Price check: month to month, Mondae lists $126 for tirzepatide and $87 for semaglutide, and Eden Health $99 for semaglutide (read November 20, 2026).

Related reading

Sources

GLP-1 program scores use the v4.1 methodology and pages read November 20, 2026; peptide and hormone clinics keep their May 2026 profiles and are not part of that ranking.